Expansion for range of cardiovascular genetic tests
Lab21 is to expand its portfolio of genetic tests for inherited cardiac syndromes.
Cardiovascular diseases
Two for one - and one for two
Philips and Steris join forces to provide hybrid surgical rooms: a flexible environment for optimal imaging during open and minimally invasive cardiovasculare procedures that will optimise workflow and streamline room planning.
NICE renewed flu guidance
The next flu season will come. To prevent high-risk people from infections, the National Institute for Health and Clinical Excellence (NICE) recently published a final guidance on the use of the drugs oseltamivir, amantadine and zanamivir for the prophylaxis of influenza. "But vaccination is the main way to prevent flu", says Gillian Leng, NICE Deputy Chief Executive.
Mystery of complicated plaques
Until recently, physicians believed that stenosis was responsible for strokes. But new investigations show that the composition of complicated plaques are the major cause. Canadian researchers now used 3-D MRI to accuratly detect bleeding by those plaques within the vessel walls.
Eat Mediterranean to stay healthy
Mediterranean diet protects against chronic diseases like heart disease, cancer, Parkinson's and Alzheimer's disease. Italian scientists bolstering one more time the idea that low intake of meat, dairy products and alcohol, but high intake of vegetables, fruits, nuts, olive oil, grains and fish servers as a model of healthy eating, according to a study in the British Medical Journal.
Be careful with your heart
New research claims that nearly four million people in the UK may be unaware they are at high risk of heart disease. An University of Oxford team screened more than 71,000 people aged over 18 across England, Wales and Scotland.
Diabetes and the heart
ESC speaker John Cleland from the University of Hull, UK, sumed up the latest treatment available for patients with diabetes mellitus and expressed his worries about side-effects and efficacy of available anti-diabetic drugs. If you want to read his ESC abstract, just click the “read more” button.
Tablets for the people?
Last week the English government closed its consultation on the effectiveness of vascular checks for high-risk people aged 40-74. Would this help? Experts from New Zealand and the WHO say "yes". Others argue that public health approaches targeting the whole population are both: cheaper and more effective than tablets.
A sad mood causes a bad heart
The common parlance knew it long before experts paid attention to it: a persons mood can be associated to its heart. But indeed in recent years much attention has been spend to depression following heart attack and its effects on prognosis. On the Congress of the European Society of Cardiology (ESC) two Dutch studies have been introduced indicating that especially somatic and incident depression…
Cardiac Devices in Heart Failure Patients assessed as beneficial
A new analysis presented during the ESC on the effects of cardiac resynchronization therapy (CRT) in patients with mild heart failure shows improvement in several areas, including left ventricular ejection fraction, a standard measure of the heart's pumping effectiveness and key indicator of heart health.
The success story of the transcatheter aortic valve replacement
It seems like the innovative non surgical technique of transcatheter aortic valve replacement heralds the start for radical changes in the field of valvular heart disease. Promising results from different clinical studys underline the positive impact.
Depression and Heart Disease
Two Dutch studies indicate that especially somatic and incident depressions are associated with poor prognosis in cardiac patients, which is very different from the 'typical' psychiatric depression that is usually characterised by cognitive and recurrent depressive symtoms.
Spotlight Cholesterol: the role of diet, statins and genetics
The inverse epidemiological association between serum levels of HDL-C and risk of coronary artery disease (CAD) is graded and has been validated in multiple studies. However, there is remaining controversy whether a low HDL-C should not predominantly be considered a marker of poor lifestyle (obesity, lack of exercise, hypertriglyceridemia, diet, etc.), rather than a primary causal agent for…
Primary prevention of CVD: Challenges and Achievements
Lifestyle and risk factor results show that recommended scientific guidelines form a contrast to what is achieved in daily practice in high risk individuals in primary prevention of CVD. Together with its partners the ESC demands a comprehensive and multisdicplinary primary prevention programme involving the high-risk population, their GP's and other health professionals, a health insurance…
Winners of media prize announced
The International Chair on Cardiometabolic Risk (ICCR) is pleased to announce the three winners of the European Media Prize co-sponsored by the ICCR and the Association of European Journalists (AEJ) and launched in November 2007 to reward articles that best inform readers about a growing public health issue: abdominal obesity and related risk of cardiovascular disease.
Mitral valve repair is the treatment of choice
"Surgery should be performed using as often as possible surgical mitral valve repair, as this treatment has shown safety, efficacy and good long-term results," says French Prof Alec Vahanian on Monday, the third ESC day.
New concept in the treatment of aortic valve disease
Transapical aortic valve implantation (TA-AVI) is a new therapeutic strategy, which has been implemented successfully into clinical practice in several hundred patients suffering symptomatic aortic stenosis and an increase perioperative risk during the past two years. The Edwards SAPIEN™ prosthesis has been used.
Robotic navigation in catheter ablation
Catheter ablation is still associated with a substantial amount of complications, and more failure then sometimes reported. Perforation with catheters is especially important in atrial fibrillation. Robotic navigation could reduce these complications.
New biomarkers in acute cardiac care
Professor C Mueller adressed the issue of new biomarkers in acute cardiac care on the ESC on Monday, 1st September. Read his comment in the following.
New biomarkers allow improved diagnosis
The BACH (Biomarkers in Acute Congestive Heart Failure) trail, an international, multi-marker study, analysed the diagnostic and prognostic precision of new biomarkers in patients with dyspnea (Shortness of Breath).
First image of a single heart cycle
The Acuson SC2000 volume imaging ultrasound system - reported to be the first system in the world to acquire non-stitched real-time full-volume 3-D images of the heart in one single heart cycle - is launched at the ESC meeting in Munich.
Intima media thickness to measure the thickness of artery walls
Intima media thickness (IMT) is a valuable research tool that can be used as surrogate end points in clinical trails, says Professor Stefan Agewall.
How save are antiangiogenic and anti-inflammatory drugs really?
Since Rofecoxib (Vioxx) was withdrawn from the worldwide market based on the safety findings of the Adenomatous Polyp Prevention on Vioxx (APPROVe) study, the uncertainty around the cardiovascular safety of NSAIDs and COX-2 inhibitors remains and leaves practitioners with difficult management decisions for the hundreds of millions of patients worldwide who continue to require pain-relieving…
Childhood obesity
Recent studies have shown that overweight and obesity during childhood and adolescence have a negative impact on the functioning of the internal walls of the arteries, paving the way to the development of an arteriosclerotic disease from an increasingly early age.
Early diagnosis
Under the banner Hear today the heartbeats of tomorrow, at this year's ESC meeting GE Healthcare will showcase its latest cardiology technology for the management of cardiovascular disease (CVD) as well as several new products.
